Project Grant K01HL177146
Award Date 8/5/26
Completion Date 7/31/31
Dollars Obligated $162K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bloomington, IN 47405, USA
Similar Awards
- The National Heart, Lung, and Blood Institute, a component of the Department of Health and Human Services National Institutes of Health, awarded $792,498 to the Trustees of Indiana University (doing business as Indiana University Indianapolis) on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate gene-environment interactions in congenital heart disease, specifically the role of maternal obesity in offspring cardiac development. The research...
- The National Heart, Lung, and Blood Institute awarded Trustees of Indiana University $249,000 on July 24, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to examine the role of structural factors in cardiovascular disease disparities. The recipient will employ data fusion techniques to create neighborhood-level structural determinants by harmonizing administrative datasets with prospective cohort data from the Women's Health Initiative (WHI). The analysis will link WHI...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Indiana University Indianapolis a Project Grant of $169,444.00 under the Cardiovascular Diseases Research program (CFDA 93.837) beginning September 5, 2025, with completion targeted for August 31, 2030. This award supports the co-development and pilot testing of a stress management intervention designed specifically for Black adults with elevated blood pressure and hypertension. The research addresses...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $1,484,930 on June 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and validate a behavioral large language model that identifies prescriptions of guideline-directed medical treatments for peripheral artery disease-related claudication in electronic health records. The project addresses suboptimal clinical implementation of proven non-invasive behavioral and pharmacologic...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $277,375 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 25, 2026, to conduct a cluster randomized controlled trial assessing the feasibility and effect of Health Strides, a six-month, multi-level physical activity intervention targeting Head Start staff. The intervention combines workplace-level and individual-level components. The workplace component establishes a wellness...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $516,592 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct integrative genomic analysis and develop high-dimensional risk prediction models for congenital heart defects using random field methods. The research leverages existing biospecimens and data from the National Birth Defect Prevention Studies, the Pediatric Cardiac Genomics Consortium, and the Trans-Omics for...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the Trustees of Indiana University (Indiana University Indianapolis) $158,036 in a Project Grant on August 17, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds development and pilot testing of four weight stigma reduction intervention components for adolescent-serving clinics, informed by lived experiences of patients and clinical leadership input. The...
- The National Heart, Lung, and Blood Institute awarded $792,498 to Trustees Of Indiana University (Indiana University Indianapolis) on August 17, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) for a Project Grant titled "Biomimetic CRISPR Nanoformulations for Targeted Gene Editing in Thalassemia and Sickle Cell Disease." The award funds development of in vivo CRISPR delivery systems using biomimetic lipid nanoparticles (LNPs) to deliver gene-editing components to...
- The National Institute of Nursing Research awarded the Trustees of Indiana University (Indiana University Indianapolis) $803,850 on September 19, 2025, under the Nursing Research program (CFDA 93.361) to develop and implement the Midwest Leadership in Education, Application, and Dissemination of Research on the Social Determinants of Health (LEADRS) program. The program provides rigorous training to nurse scientists and aligned health professionals in conceptual frameworks, research methods, and...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $275,256 on April 1, 2026, for a project grant (CFDA 93.837, Cardiovascular Diseases Research) titled "In-Vivo and Ex-Vivo Analysis of Tissue S-Nitrosothiols in Sepsis." The award funds a five-year program of mentored research support and investigation into the role of S-nitrosothiols in sepsis pathophysiology. The research objective is to define the role of S-nitrosothiols in blood and...